Dalrada Technology Group, Inc.

DHTI OTC CIK: 0000725394

Company Information

Industry Services-Help Supply Services
SIC Code 7363
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation WY
Business Address 600 LA TERRAZA BOULEVARD, ESCONDIDO, CA, 92025
Mailing Address 600 LA TERRAZA BOULEVARD, ESCONDIDO, CA, 92025
Phone 858-283-1253
Fiscal Year End 0630
EIN 383713274

Financial Overview

FY2025

-$24.65M
Net Income
$25.05M
Total Liabilities
$3.44M
Stockholders' Equity
$813K
Cash & Equivalents
$-0.23
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K/A Current report amendment February 2, 2026 View on SEC
8-K Current report of material events January 27, 2026 View on SEC
8-K Current report of material events January 20, 2026 View on SEC
10-Q Quarterly financial report November 14, 2025 View on SEC
8-K Current report of material events November 6, 2025 View on SEC
10-K Annual financial report September 30, 2025 View on SEC
10-Q Quarterly financial report August 1, 2025 View on SEC
10-Q Quarterly financial report July 21, 2025 View on SEC
10-Q Quarterly financial report June 23, 2025 View on SEC
10-Q/A Quarterly report amendment June 6, 2025 View on SEC

Annual Reports

10-K September 30, 2025
  • Improved gross profit 5x to $5.3 million through 20% cost reduction
  • Converted $1.5M debt to preferred stock and resolved $47K performance obligation
View Analysis

Material Events

8-K Other January 27, 2026
High Impact
  • Genefic Inc. secured a substantial financing package, including up to $20 million in financial guarantees and a $5 million revolving credit facility from IBS Investment Bank.
  • The financing aims to boost Genefic's healthcare operations, particularly its specialty pharmacy services, and provide working capital for growth.
View Analysis

Related Companies

Companies in the same industry (SIC: 7363)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.